NINDS Neuroscience Funding Announcements

This PA, with a $2 million NIDDK annual set-aside, is intended to stimulate the application of new molecular technologies to this area. An understanding of the tissue and cell specific expression of growth factors in the eye, kidney, mouth, nerves and vessels, and of the molecular action of these growth factors in the pathophysiology of complications will lead to improved and more specific therapies.